Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Amortization of Deferred Charges (2025)

Nuvation Bio (NUVB) has disclosed Amortization of Deferred Charges for 1 consecutive years, with $431000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Amortization of Deferred Charges changed N/A to $431000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $644000.0, a N/A change, with the full-year FY2025 number at $662000.0, changed N/A from a year prior.
  • Amortization of Deferred Charges was $431000.0 for Q4 2025 at Nuvation Bio, up from $213000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $431000.0 in Q4 2025 to a low of $213000.0 in Q3 2025.